ISB News

ISB at Town Hall Seattle on March 18

Mark your calendars for 7:30 p.m. on March 18 to join ISB for a panel discussion about “Tipping Points in Environment and Climate.” The event takes place at Downstairs at Town Hall. Tickets are $5. Info: townhallseattle.org/event/isb-panel

Panel description:

So-called tipping points — sudden, large-scale environmental changes — are altering our ecosystem in non-intuitive ways that defy our sense of causation. Because the nature of these shifts makes them unexpected, Seattle’s Institute for Systems Biology is using cutting-edge analysis, systems-level thinking, and an interdisciplinary approach to advance research in this field. This moderated forum (with an introduction by ISB Co-founder and President Leroy Hood) will discuss the basic principles of tipping point dynamics, the early warning signs for these events, why basic human intuition is missing the mark in this area, and how we can adapt our thinking about the future of the planet. Panelists include moderator Luke Timmerman, biotechnology journalist; Dr. Stuart Kauffman, Affiliate Faculty at the Institute for Systems Biology and author; Dr. Lauren Buckley, Assistant Professor at the University of Washington’s Department of Biology; and Dr. Dennis Hartmann, Professor at the University of  Washington’s Department of Atmospheric Sciences.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.